192,510.00

The report gives the overview of Primary progressive multiple sclerosis disease indication in detail, highlights the PPMS epidemiology in the present scenario and in future (forecasted) as well in the key geographies across the globe and elaborates on the drugs prescribed and expected to be prescribed in PPMS by the physicians . The report starts with the basic definition, causes and symptoms of Multiple Sclerosis and further details the types of Multiple Sclerosis disease indication.

The report elaborates on the Primary Progressive Multiple Sclerosis disease indication detailing the definition, causes, profile of a PPMS patient, Symptoms of PPMS patient, and disease progression in a PPMS patient. The report further highlights the multiple methods through which the patient can be diagnosed for PPMS. The middle part of the report consists of PPMS epidemiology and prevalence in the key geographies across the globe like US, UK, Germany, Italy, France, Spain, Japan etc. The epidemiology for PPMS indication across key geographies has been forecasted till 2024 as well in the report.

The later part of the report highlights the importance of factors influencing the physician prescription decisions in PPMS like efficacy factors, Tolerability factors, Monitoring requirements and pricing factors. The report further details the drugs prescribed or expected to be prescribed in PPMS by the physicians in terms of details about the formulation, molecule, mode of administration and MoA of the drugs, their patent and trial details and the expected impact of drug in the PPMS market.

Price: USD 6000

*Special Offer Price: USD 3000

For Table of content Click Here

For any queries regarding the report please email at sales@pharmascroll.com and we would get back to you in the shortest possible time.